Upholding LCA policy on PCa agents would save $33M

If least costly alternative (LCA) policies for certain prostate cancer drugs had not been rescinded in 2010, Medicare expenditures would have been reduced by more than $33 million over 1 year, a new government report suggests.
Source: Modern Medicine - Category: Journals (General) Source Type: news